Follow Us On Social Media

 
 
READ ARTICLE

NEJM Publishes Phase 3 Data for Epidiolex in Dravet Syndrome as Manufacturer Eyes Mid-2017 NDA Submission

The New England Journal of Medicine has published results from a Phase 3 study showing that Epidiolex (cannabidiol, GW Pharmaceuticals) reduces monthly convulsive seizure frequency compared to placebo in children with Dravet syndrome. The study randomized 120 children ages two to 18 years with Drave…

READ ARTICLE

Celgene’s Investigational MS Agent Reduces Annual Relapse Rate but Falls Short of Disability Endpoint in Phase 3 Trial

READ ARTICLE

Migraine Prevalence Higher in Collegiate Athletes, New Study Finds

READ ARTICLE

Endovascular Intervention Found Effective for "Late Window" Stroke Patients: DAWN Trial Analysis

READ ARTICLE

Endovascular Intervention Found Effective for “Late Window” Stroke Patients: DAWN Trial Analysis

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

Steve Farrell
National Sales Manager
973-768-8681
sfarrell@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC